Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Aims: Mechanical thrombectomy (MT) is an effective treatment for acute ischemic stroke due to large vessel occlusion (LVO). Atrial fibrillation (AF) can be known before the stroke (or prevalent AF) or be newly detected after the stroke (post-stroke AF). Inflammation plays a critical role in the pathogenesis of post-stroke AF, making inflammatory markers valuable for early detection of post-stroke AF. This study investigated the predictive value of C-reactive protein (CRP) and other inflammatory biomarkers in predicting post-stroke AF in acute ischemic stroke patients treated with MT.

Methods: This observational multicenter retrospective cohort study included 849 patients with anterior circulation LVO treated with MT across four centers from 2016 to 2023. Patients were divided into post-stroke AF and NO-AF groups, excluding those with prevalent AF. Baseline demographics, clinical and procedural variables, and inflammatory biomarkers, including CRP, were collected at admission and 24-h post-procedure. Baseline characteristics were balanced using inverse probability weighting (IPW). Logistic regression and receiver operating characteristic (ROC) analyses assessed the predictive value of CRP for post-stroke AF.

Results: The study included 849 patients with a median age of 66 years (interquartile range (IQR) = 54-76) and 477 (56.2%) were female. Post-stroke AF was detected in 186 (21.9%) patients, while 663 (78.1%) did not experience AF during admission. In the weighted population, CRP levels, both admission and 24-h post-procedure, were higher in post-stroke AF patients. In logistic regression analysis, admission and 24-h CRP levels were associated with increased probability of post-stroke AF, respectively (odds ratio (OR) = 1.01; 95% confidence interval (CI) = 1.00-1.03, p < 0.001) and (OR = 1.02, 95% CI = 1.01-1.03, p < 0.001) following MT. We observed that the model combining age, sex, hypertension, heart failure, alcoholism, coronary artery disease, diabetes mellitus, smoking, previous transient ischemic attack (TIA), and ischemic stroke, and admission CRP (area under the curve (AUC) = 0.723, 95% CI = 0.71-0.74) and 24-h CRP (AUC = 0.704, 95% CI = 0.69-0.72) had good predictive accuracy, with optimal cutoff values of 4.25 for admission CRP and 14.69 for 24-h CRP to detect post-stroke AF. Subgroup analysis indicated CRP predictive relevance, particularly in hypertensive patients.

Conclusions: Our findings suggest CRP is associated with post-stroke AF in stroke patients due to LVO, highlighting inflammation's role in AF pathogenesis. Measuring CRP at admission and 24 h may enable early detection and timely anticoagulation. Incorporating CRP into clinical pathways could improve individualized risk assessment, warranting further studies to validate its predictive utility and explore additional markers.

Download full-text PDF

Source
http://dx.doi.org/10.1177/17474930251332489DOI Listing

Publication Analysis

Top Keywords

ischemic stroke
12
admission 24-h
12
post-stroke
9
c-reactive protein
8
atrial fibrillation
8
mechanical thrombectomy
8
inverse probability
8
probability weighting
8
acute ischemic
8
inflammatory biomarkers
8

Similar Publications

20(R)-ginsenoside Rg3 Inhibits Neuroinflammation Induced by Cerebral Ischemia/Reperfusion Injury by Regulating the Toll-Like Receptor 4/Myeloid Differentiation Factor-88/Nuclear Factor Kappa B Signaling Pathway.

Chem Biodivers

September 2025

School of Pharmaceutical Science, Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, P. R. China.

20(R)-ginsenoside Rg3 can reduce the effects of oxidative stress and cell death in cerebral ischemia‒reperfusion injury (CIRI). Neuroinflammation is crucial post-CIRI, but how 20(R)-Rg3 affects ischemia‒reperfusion-induced neuroinflammation is unclear. To study 20(R)-Rg3's effects on neuroinflammation and neuronal preservation in stroke models and explore toll-like receptor 4/myeloid differentiation factor-88/nuclear factor kappa B (TLR4/MyD88/NF-κB) pathway mechanisms.

View Article and Find Full Text PDF

Kidney stone disease increases the risk of cardiovascular events.

PLoS One

September 2025

Department of Cardiology, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, Fujian, China.

Introduction: Kidney stone disease is associated with numerous cardiovascular risk factors. However, the findings across studies are non-uniformly consistent, and the control of confounding variables remains suboptimal. This study aimed to investigate the association between kidney stone and cardiovascular disease.

View Article and Find Full Text PDF

Arterial thrombosis is a multifaceted process characterized by platelet aggregation and fibrin deposition, leading to the occlusion of blood vessels. It plays a central role in cardiovascular conditions such as myocardial infarction and ischemic stroke. Gaining insight into the mechanisms underlying arterial thrombosis is essential for developing effective treatments aimed at preventing thrombotic events and reducing associated health burdens.

View Article and Find Full Text PDF

Background: The benefits of rehabilitation in acute ischemic stroke patients following thrombectomy remain underexplored. We assessed which activities of daily living (ADLs) show the greatest improvement after goal-directed therapy in an inpatient rehabilitation setting.

Methods: We retrospectively analyzed pre- and post-rehabilitation functional assessments in 40 acute ischemic stroke patients treated with mechanical thrombectomy.

View Article and Find Full Text PDF

Acute ischemic stroke (AIS) remains a leading cause of mortality and long-term disability globally, with survivors at high risk of recurrent stroke, cardiovascular events, and post-stroke dementia. Statins, while widely used for their lipid-lowering effects, also possess pleiotropic properties, including anti-inflammatory, endothelial-stabilizing, and neuroprotective actions, which may offer added benefit in AIS management. This article synthesizes emerging evidence on statins' dual mechanisms of action and evaluates their role in reducing recurrence, improving survival, and mitigating cognitive decline.

View Article and Find Full Text PDF